As speculated, compared with the vehicle group, the distribution of CD3+, CD4+ and CD8+ T cells in the tumor were slightly enhanced after ICG@PM@NP treatment (Fig. 6E; Additional file 1: Fig. S10). Here, CD8A is linked to neoplasm.